The transcription factor T-bet regulates intestinal inflammation mediated by interleukin-7 receptor+ innate lymphoid cells N Powell, AW Walker, E Stolarczyk, JB Canavan, MR Gökmen, E Marks, ... Immunity 37 (4), 674-684, 2012 | 364 | 2012 |
Infection and systemic inflammation, not ammonia, are associated with Grade 3/4 hepatic encephalopathy, but not mortality in cirrhosis DL Shawcross, Y Sharifi, JB Canavan, AD Yeoman, RD Abeles, NJ Taylor, ... Journal of hepatology 54 (4), 640-649, 2011 | 311 | 2011 |
Developing in vitro expanded CD45RA+ regulatory T cells as an adoptive cell therapy for Crohn's disease JB Canavan, C Scottà, A Vossenkämper, R Goldberg, MJ Elder, I Shoval, ... Gut 65 (4), 584-594, 2016 | 201 | 2016 |
CD 161 expression characterizes a subpopulation of human regulatory T cells that produces IL‐17 in a STAT 3‐dependent manner B Afzali, PJ Mitchell, FC Edozie, GAM Povoleri, SE Dowson, L Demandt, ... European journal of immunology 43 (8), 2043-2054, 2013 | 153 | 2013 |
Comparison of regulatory T cells in hemodialysis patients and healthy controls: implications for cell therapy in transplantation B Afzali, FC Edozie, H Fazekasova, C Scotta, PJ Mitchell, JB Canavan, ... Clinical Journal of the American Society of Nephrology 8 (8), 1396-1405, 2013 | 111 | 2013 |
Interleukin 6 increases production of cytokines by colonic innate lymphoid cells in mice and patients with chronic intestinal inflammation N Powell, JW Lo, P Biancheri, A Vossenkämper, E Pantazi, AW Walker, ... Gastroenterology 149 (2), 456-467. e15, 2015 | 97 | 2015 |
Improved insulin sensitivity despite increased visceral adiposity in mice deficient for the immune cell transcription factor T-bet E Stolarczyk, CT Vong, E Perucha, I Jackson, MA Cawthorne, ET Wargent, ... Cell metabolism 17 (4), 520-533, 2013 | 95 | 2013 |
A rapid diagnostic test for human regulatory T-cell function to enable regulatory T-cell therapy JB Canavan, B Afzali, C Scottà, H Fazekasova, FC Edozie, TT Macdonald, ... Blood, The Journal of the American Society of Hematology 119 (8), e57-e66, 2012 | 93 | 2012 |
Determining the economic cost of ICU treatment: a prospective “micro-costing” study AM McLaughlin, J Hardt, JB Canavan, MB Donnelly Intensive care medicine 35, 2135-2140, 2009 | 68 | 2009 |
Molecular comparison of adult and pediatric ulcerative colitis indicates broad similarity of molecular pathways in disease tissue K Li, R Strauss, J Ouahed, D Chan, SE Telesco, DS Shouval, JB Canavan, ... Journal of pediatric gastroenterology and nutrition 67 (1), 45-52, 2018 | 51 | 2018 |
Relative resistance of human CD4+ memory T cells to suppression by CD4+ CD25+ regulatory T cells B Afzali, PJ Mitchell, C Scotta, J Canavan, FC Edozie, H Fazekasova, ... American Journal of Transplantation 11 (8), 1734-1742, 2011 | 45 | 2011 |
High-dimensional immune phenotyping and transcriptional analyses reveal robust recovery of viable human immune and epithelial cells from frozen gastrointestinal tissue L Konnikova, G Boschetti, A Rahman, V Mitsialis, J Lord, C Richmond, ... Mucosal immunology 11 (6), 1684-1693, 2018 | 39 | 2018 |
Transcriptional regulation of the mucosal immune system mediated by T-bet N Powell, JB Canavan, TT MacDonald, GM Lord Mucosal immunology 3 (6), 567-577, 2010 | 33 | 2010 |
Low-dose interleukin-2 ameliorates colitis in a preclinical humanized mouse model JA Goettel, D Kotlarz, R Emani, JB Canavan, L Konnikova, D Illig, SM Frei, ... Cellular and Molecular Gastroenterology and Hepatology 8 (2), 193-195, 2019 | 29 | 2019 |
Significant psychological morbidity occurs in irritable bowel syndrome: a case‐control study using a pharmacy reimbursement database JB Canavan, K Bennett, J Feely, CA O’MORÁIN, HJ O’CONNOR Alimentary pharmacology & therapeutics 29 (4), 440-449, 2009 | 27 | 2009 |
Full, partial, and modified permutations of the Mayo score: characterizing clinical and patient-reported outcomes in ulcerative colitis patients AN Naegeli, T Hunter, Y Dong, B Hoskin, C Middleton-Dalby, ... Crohn's & Colitis 360 3 (1), otab007, 2021 | 22 | 2021 |
A survey of MRSA awareness and knowledge among the general public and patients' visitors AM McLaughlin, JB Canavan, EJ Adams, R McDonagh, H Brar, ... British Journal of Infection Control 9 (5), 18-23, 2008 | 18 | 2008 |
DOP42 Efficacy and safety of deucravacitinib, an oral, selective tyrosine kinase 2 inhibitor, in patients with moderately-to-severely active Ulcerative Colitis: 12-week results … S Danese, R Panaccione, G D’Haens, L Peyrin-Biroulet, S Schreiber, ... Journal of Crohn's and Colitis 16 (Supplement_1), i091-i092, 2022 | 15 | 2022 |
Immunologic alterations associated with oral delivery of anti-CD3 (OKT3) monoclonal antibodies in patients with moderate-to-severe ulcerative colitis EK Boden, JB Canavan, CJ Moran, K McCann, WA Dunn, FA Farraye, ... Crohn's & Colitis 360 1 (2), otz009, 2019 | 14 | 2019 |
Artificial intelligence in inflammatory bowel disease endoscopy: implications for clinical trials HA Ahmad, JE East, R Panaccione, S Travis, JB Canavan, K Usiskin, ... Journal of Crohn's and Colitis 17 (8), 1342-1353, 2023 | 12 | 2023 |